TY - JOUR
T1 - A pathway-based genetic score for inflammation
T2 - An indicator of vulnerability to phthalate-induced adverse neurodevelopment outcomes
AU - Elagali, Ahmed
AU - Eisner, Alex
AU - Tanner, Samuel
AU - Drummond, Katherine
AU - Symeonides, Christos
AU - Love, Chloe
AU - Tang, Mimi LK
AU - Mansell, Toby
AU - Burgner, David
AU - Collier, Fiona
AU - Sly, Peter D.
AU - O'Hely, Martin
AU - Dunlop, Sarah
AU - Vuillermin, Peter
AU - Ponsonby, Anne Louise
N1 - Publisher Copyright:
© 2024 The Authors
PY - 2025/3
Y1 - 2025/3
N2 - Introduction: Phthalates, chemical additives used to enhance plastic products' flexibility, are easily released into the environment, and can harm the brain development through various mechanisms including inflammation. Genetic variation influencing an individual's susceptibility to inflammation may play a role in the effects of phthalate exposure on neurodevelopment however there is no summary measure developed for genetic susceptibility to inflammation. Methods: We developed a genetic pathway function score for inflammation (gPFSin), based on the transcriptional activity of the inflammatory response pathway in the brain and other tissues. Using the Barwon Infant Study (a birth cohort of n = 1074), we examined the connection between gPFSin and key neurodevelopmental outcomes, along with the interplay between prenatal phthalate levels, children's genetic susceptibility to inflammation (gPFSin), and adverse neurodevelopmental outcomes. Results: Regression techniques revealed consistent associations between gPFSin-phthalate combinations and key neurodevelopmental outcomes. A high gPFSin score was associated with an increased risk of doctor-diagnosed Autism Spectrum Disorder (ASD) and Attention-Deficit/Hyperactivity Disorder (ADHD) by age 11.5 years, with adjusted odds ratios of 2.15 (p = 0.039) and 2.42 (p = 0.005), respectively. Furthermore, individuals with both high gPFSin and prenatal phthalate exposure exhibited more neurodevelopmental problems. This included associations of high gPFSin and bis(2-ethylhexyl) phthalate (DEHP) levels with parent-reported ASD traits and doctor-diagnosed ASD. The attributable proportions due to this interaction were 0.39 (p = 0.045) and 0.37 (p = 0.037), respectively. Conclusion: These findings contribute to the evidence linking gestational phthalate exposure and inflammation to adverse neurodevelopment and underscoring increased risks in children with higher genetic susceptibility to inflammation.
AB - Introduction: Phthalates, chemical additives used to enhance plastic products' flexibility, are easily released into the environment, and can harm the brain development through various mechanisms including inflammation. Genetic variation influencing an individual's susceptibility to inflammation may play a role in the effects of phthalate exposure on neurodevelopment however there is no summary measure developed for genetic susceptibility to inflammation. Methods: We developed a genetic pathway function score for inflammation (gPFSin), based on the transcriptional activity of the inflammatory response pathway in the brain and other tissues. Using the Barwon Infant Study (a birth cohort of n = 1074), we examined the connection between gPFSin and key neurodevelopmental outcomes, along with the interplay between prenatal phthalate levels, children's genetic susceptibility to inflammation (gPFSin), and adverse neurodevelopmental outcomes. Results: Regression techniques revealed consistent associations between gPFSin-phthalate combinations and key neurodevelopmental outcomes. A high gPFSin score was associated with an increased risk of doctor-diagnosed Autism Spectrum Disorder (ASD) and Attention-Deficit/Hyperactivity Disorder (ADHD) by age 11.5 years, with adjusted odds ratios of 2.15 (p = 0.039) and 2.42 (p = 0.005), respectively. Furthermore, individuals with both high gPFSin and prenatal phthalate exposure exhibited more neurodevelopmental problems. This included associations of high gPFSin and bis(2-ethylhexyl) phthalate (DEHP) levels with parent-reported ASD traits and doctor-diagnosed ASD. The attributable proportions due to this interaction were 0.39 (p = 0.045) and 0.37 (p = 0.037), respectively. Conclusion: These findings contribute to the evidence linking gestational phthalate exposure and inflammation to adverse neurodevelopment and underscoring increased risks in children with higher genetic susceptibility to inflammation.
KW - Attention-deficit/hyperactivity disorder
KW - Autism
KW - Cytokine
KW - Genetic score
KW - Inflammation
KW - Phthalate
UR - http://www.scopus.com/inward/record.url?scp=85212928292&partnerID=8YFLogxK
U2 - 10.1016/j.ijheh.2024.114514
DO - 10.1016/j.ijheh.2024.114514
M3 - Article
C2 - 39721371
AN - SCOPUS:85212928292
SN - 1438-4639
VL - 264
JO - International Journal of Hygiene and Environmental Health
JF - International Journal of Hygiene and Environmental Health
M1 - 114514
ER -